Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Forget Treasury Bonds: This 6%-Yielding Pharma Stock Pays You to Wait for Its Pipeline
Treasury bonds offer steady, risk-free income, but Pfizer (PFE +2.59%) brings something extra to the table: a roughly 6% dividend yield and the potential for a massive turnaround. The pharmaceutical giant is expanding its portfolio beyond its…
Zydus Sunshine to invest over $20 million in Sri Lanka pharma plant
Zydus Sunshine Lifesciences, a joint venture between Zydus Lifesciences Ltd and Sunshine Healthcare, has signed an agreement with the Board of Investment of Sri Lanka to set up a pharmaceutical manufacturing facility in the island nation, according…
MEPs pause vote on EU pesticides bill, as UN experts join scientists in opposition to Big Pharma
A backlash is building against an EU ‘omnibus' bill that seeks to make it easier to authorise and use pesticides across the bloc. MEPs are still yet to set a date to vote on the European Commission's proposal to extend how long pesticide…
Agility, Access And Scale: 3 Factors Defining Biotech's Future
Brian O'Shaughnessy is Chief Commercial Officer at Uniphar. As one of the leading genetic causes of infant mortality, spinal muscular atrophy (SMA) is a devastating neuromuscular disease that progressively strips young children of the ability to…
Royalty Pharma (NASDAQ:RPRX) Stock Jumps 3.3% - Here's Why
Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report)'s stock price rose 3.3% on Wednesday. The stock traded as high as $58.45 and last traded at $58.4550. Approximately 722,411 shares changed hands during trading, a decline of 79% from the average…
Ascendis Pharma A/S $ASND Shares Newly Purchased by Avior Wealth Management LLC
Avior Wealth Management LLC bought a new position in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund bought 5,236 shares of the biotechnology company's…
IT Stocks Gain Rs 25,029 Crore
Pharma stocks lost Rs 25,169 crore. India's information technology (IT) stocks added Rs 25,029 crore in market value on Wednesday, October 14, 2026, almost exactly matching the loss suffered by the pharmaceutical (pharma) sector, as investors…
Japan's Nikkei slumps 5 percent as tech stocks hammered by AI, rate hike worries
Japan's Nikkei share average tumbled nearly 5 percent on Thursday, with tech stocks hit hard by media reports about distressed debt at US cloud-computing provider CoreWeave, while hot US inflation figures sparked fears of higher interest rates.
Pressure builds on Jackson to disclose campaign finances in Maine Senate race
Democratic hopeful Troy Jackson is facing pressure to disclose his campaign donors in the Maine Senate race, with early voting now underway in the key midterm battle. While on the campaign trail, Republican candidate and the five-term incumbent…
Sensex fell 252 points and more shares went up than down
The Sensex fell 252 points on Wednesday to 72,781.89, with the Nifty down 99.25 to 22,622.70 — a mild giveback after Tuesday's 1.6 per cent surge. Crude climbing towards 107 dollars did the damage, and IT was the only sector that mattered.
Coursera: Downgraded To Hold Ahead Of Q3 Results, Awaiting Merger Progress (NYSE:COUR)
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
Sterling Infrastructure: A Long Growth Runway Ahead (NASDAQ:STRL)
Sterling Infrastructure is rated Buy, supported by robust data-center demand, strong backlog growth, and a multiyear growth runway across end markets. STRL's acquisition of CEC enhances electrical services, enabling cross-selling and deeper…
AriBio, Fosun, And Alzheimer's Disease: Close, But Perhaps Not Enough (OTCMKTS:SFOSF)
AriBio is nearing phase 3 results for AR1001, a phosphodiesterase-5 inhibitor that limits peroxynitrite-mediated damage in Alzheimer's disease. Shanghai Fosun Pharmaceuticals (SFOSF) secured regional rights to AR1001 via a $60M option fee, with up…
Generate Biomedicines: Zealand Deal For Obesity Programs May Not Be Quite What It Seems
Generate Biomedicines maintains a Hold rating as it pivots into obesity/metabolic disease via a $1.2bn milestone-driven partnership with Zealand Pharma. GENB's lead asset, GB-0895, faces a high-stakes Phase 3 asthma readout, with non-inferiority to…
Britain's Military-Industrial Complex Is Promoting War Fever
War fever has gripped the European political establishment. War in Ukraine and rumors of continent-wide conflict with Russia are now the staple justification for rearmament, ballooning arms budgets, and the reintroduction of conscription across…
Receive a Daily briefing on Pharma Industry News
Get Started